Valeant Pharmaceuticals North America LLC is recalling 25,525 bottles of Cardizem CD (diltiazem HCl) and Diltiazem HCl CD extended-release capsules. These blood pressure medications were found to have failed dissolution specifications, meaning they may release the medication into the body faster or slower than intended. Because this could affect how well the medicine works or lead to side effects, consumers should check their bottles for specific lot numbers and expiration dates. If you have the affected medication, contact your healthcare provider or pharmacist for guidance and return the product to the pharmacy.
The drug failed dissolution testing, resulting in high out-of-specification measurements for the amount of medication released at certain time intervals. If the drug is released too quickly, it could potentially lead to an overdose or increased side effects, while releasing too slowly could make the treatment for blood pressure and chest pain less effective.
Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.